NEW ENGLAND PEDIATRIC ONCOLOGY CONSORTIUM

本项目的目标是继续发展和提高 由四个新英格兰人组成的高效运作联盟的生产率 儿科癌症中心(布朗大学/罗德岛医院； 达特茅斯-希区柯克医学中心-诺里斯·科顿癌症中心；哈佛大学 大学/马萨诸塞州总医院；佛蒙特州大学/医学院 中心医院-佛蒙特州区域癌症中心)的目的： A.有助于理解和对待童年 通过以下途径引发恶性肿瘤： 1.通过积极参与国家合作研究，为国家合作研究提供投入 儿科肿瘤学小组(POG)： A.患者应计：实现显著的患者数量和质量 有关协议的条目。 B.研究开发和评估：协助开发新的 通过委员会成员资格、机构审查提出的议定书 协议设计，研究结果的批判性分析，并提出新的 基于NEPOC研究的POG实施协议(包括 通过新的实验室方法识别隐匿性中枢神经系统白血病)。 2.促进和促进国家环境政策中心内部的合作努力 共同关注儿童恶性肿瘤领域的研究，#年 特别是为POG开发潜在的试点研究。 B.加强对患癌症儿童的地域护理 NEPOC成员机构通过以下方式提供服务的领域： 1.确保对儿童恶性肿瘤进行全面和现代化的管理 作为全国儿童肿瘤学合作组织成员的一项福利 研究组； 2.在每个国家分享工作人员的专门知识和调查设施 NEPOC中心； 3.合力推动香港本土教育 儿童癌症的领域。 通过集中管理，该联盟将整合 活动和资源(工作人员、调查机构、患者) 四个成员机构中的每一个都纳入一个单一的计划，旨在 实现这些目标。

The objective of this project is the continued development and enhanced productivity of an efficiently functioning consortium of four New England pediatric cancer centers (Brown University/Rhode Island Hospital; Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center; Harvard University/Massachusetts General Hospital; University of Vermont/Medical Center Hospital-Vermont Regional Cancer Center) for the purpose of: A. Contributing to the understanding and treatment of childhood malignancies through: 1. Input into national cooperative studies through active membership in the Pediatric Oncology Group (POG): a. Patient Accrual: Achieve significant number and quality of patient entries on protocols. b. Study Development and Evaluation: Assist in the development of new protocols through committee membership, institution review of proposed protocol designs, critical analysis of study results, and proposal of new protocols for POG implementation based on NEPOC studies (including identification of occult CNS leukemia through new laboratory methodology). 2. Stimulation and facilitation of cooperative efforts within NEPOC in studies of joint interest in the area of childhood malignancies, in particular toward developing potential pilot studies for POG. B. Enhancement of the care of children with cancer in the geographical areas served by the NEPOC member institutions through: 1. Assuring comprehensive and modern management of childhood malignancies as a benefit of membership in a national cooperative pediatric oncology study group; 2. Sharing the staff expertise and investigative facilities at each of the NEPOC centers; 3. Joint efforts in the promotion of education of the local community in the area of cancer in children. Through a centralized administration, this Consortium will integrate the activities and resources (staff, investigative facilities, patients) at each of the four member institutions into a single program aimed at achieving these goals.